Cox Eb
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 2
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 3
- Estrogen and related hormone effects 2
- Rheumatology top 1%
- Oncology top 5%
- HER2/EGFR in Cancer Research 3
- Bone health and treatments 1
- Cancer Research top 5%
- Breast Cancer Treatment Studies 1
-
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- McCarty KsJohn G. KonrathMiller LsJE SokalMichele BaccaraniFrancisco CervantesS TuraGA Gomez
- Cited by
- HematologyGeneticsRheumatology
- Journals
- Blood (4 papers)PubMed (6 papers)
- Partner nations
- United States
In The Last Decade
Cox Eb
10 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Hematology 1.3k
- Genetics 1.2k
- Rheumatology 668
- Oncology 685
- Cancer Research 369
Countries citing papers authored by Cox Eb
This map shows the geographic impact of Cox Eb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cox Eb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cox Eb more than expected).
Fields of papers citing papers by Cox Eb
This network shows the impact of papers produced by Cox Eb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cox Eb. The network helps show where Cox Eb may publish in the future.
Co-authorship network
The 23 scholars most cited alongside Cox Eb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase II study of human lymphoblastoid interferon in patients with multiple myeloma. | 1988 | 4 |
| 2 | Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. | 1986 | 363 |
| 3 | Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.breakdown → | 1985 | 882 |
| 4 | 1984 | 40 | |
| 5 | Clinical response to hormone therapy correlated with estrogen receptor analyses. Biochemical v histochemical methods. | 1984 | 10 |
| 6 | Elastosis in human breast cancer. Correlation with sex steroid receptors and comparison with clinical outcome. | 1984 | 17 |
| 7 | 1984 | 4 | |
| 8 | Sex related survival differences in instances of melanoma. | 1984 | 25 |
| 9 | Prognostic discrimination in "good-risk" chronic granulocytic leukemiabreakdown → | 1984 | 646 |
| 10 | Prognostic discrimination in "good-risk" chronic granulocytic leukemiabreakdown → | 1984 | 722 |
About Cox Eb
Cox Eb is a scholar working on Genetics, Hematology and Oncology, having authored 10 papers that have together received 2.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Acute Myeloid Leukemia Research (2 papers), Estrogen and related hormone effects (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper), Bone health and treatments (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Hematology (1.3k citations), Genetics (1.2k citations) and Rheumatology (668 citations). Cox Eb has collaborated with scholars based in United States. Frequent co-authors include McCarty Ks, John G. Konrath, Miller Ls, JE Sokal, Michele Baccarani, Francisco Cervantes, S Tura, GA Gomez, C. Y. Tso and BD Clarkson. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.